Eli Lilly’s “triple g” drug helped patients lose about 28.7% of their body weight while also reducing pain associated with knee osteoarthritis in a Phase 3 trial.
www.marketwatch.com
#Eli #Lillys #newest #weightloss #drug #relieved #pain #patients #knee #osteoarthritis
Related Posts

If You Don’t Negotiate Your Bills, You Could Be Overpaying Hundreds in 2026
People’s budgets and paychecks are stretched especially thin as 2025 starts to slow to a close, accommodating the increased cost…

Target Delivers 54th Consecutive Annual Dividend Hike
Target Corporation (NYSE:TGT) is one of the best stocks for a retirement stock portfolio. On June 12, the company’s board…

This retired Georgia couple’s ACA premium doubled to $39,000 a year after subsidies ended. How to plan for higher costs
With professional backgrounds in economics and accounting, Barbara Brockway and Matt Padula might seem like they’d be able to have…

